Skip to main content

Advertisement

SpringerLink
Log in

Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Controversy continues whether acute panmyelosis with myelofibrosis (APMF) exists as a well-defined clinicopathological entity. Following exclusion of overt acute myeloid leukemia (AML), especially the megakaryoblastic subtype, a retrospective study was performed on 46 patients with clinical and morphological features suggesting the diagnosis of APMF. All patients had a bone marrow (BM) biopsy performed at onset, and 13 had follow-up examinations. Enzyme histochemical and immunohistochemical techniques were applied and BM features evaluated by a semiquantitative scoring system. Clinical findings consisted of pancytopenia associated with a left-shifted differential count of the peripheral blood (less than 5% blasts) and no or minor splenomegaly. During follow-up (median survival 9 months) 35 patients developed severe BM insufficiency and 10 transformed into overt AML. Although myelofibrosis was a characteristic finding, other BM features proved to be heterogeneous. Cellularity was reduced in 13 and increased in 25 specimens. Most prominent was a left-shifted, often macrocytic erythropoiesis and a maturation defect of the neutrophil series. In 15 patients an increase (less than 20%) in CD34+ progenitors, immature myelomonocytic cells, and megakaryoblasts was noted. Abnormalities of megakaryocytes (atypical microforms, clustering, dysplasia) were regularly present. The stroma showed an inflammatory reaction (perivascular plasmacytosis, lymphoid nodules, many macrophages, iron deposits) in about 50% of the samples. Sequential BM biopsies revealed an accumulation of lysozyme-expressing myelomonocytic and CD34+ progenitor cells suggesting an increase in blasts. In conclusion, APMF may not be a distinct entity, but includes hyperfibrotic myelodysplastic syndromes (MDS) either primary or secondary, a rare form of initial AML with fibrosis, and even cases of toxic myelopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Amberger DM, Saleem A, Kemp BL, Truong LD (1990) Acute myelofibrosis—a leukemia of pluripotent stem cell. A report of three cases and review of the literature. Ann Clin Lab Sci 20:409–414

    CAS  PubMed  Google Scholar 

  2. Aul C, Gattermann N, Schneider W (1992) Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 82:358–367

    CAS  PubMed  Google Scholar 

  3. Bain BJ, Catovsky D, O’Brien M, Prentice HG, Lawlor E, Kumaran TO, McCann SR, Matutes E, Galton DA (1981) Megakaryoblastic leukemia presenting as acute myelofibrosis—a study of four cases with the platelet-peroxidase reaction. Blood 58:206–213

    CAS  PubMed  Google Scholar 

  4. Bass RD, Pullarkat V, Feinstein DI, Kaul A, Winberg CD, Brynes RK (2001) Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. Am J Clin Pathol 116:211–216

    CAS  PubMed  Google Scholar 

  5. Bauermeister DE (1971) Quantitation of bone marrow reticulin—a normal range. Am J Clin Pathol 56:24–31

    CAS  PubMed  Google Scholar 

  6. Bearman RM, Pangalis GA, Rappaport H (1979) Acute (“malignant”) myelosclerosis. Cancer 43:279–293

    CAS  PubMed  Google Scholar 

  7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French–American–British Cooperative Group. Ann Intern Med 103:460–462

    CAS  PubMed  Google Scholar 

  8. Bird T, Proctor SJ (1977) Malignant myelosclerosis. Myeloproliferative disorder or leukemia? Am J Clin Pathol 67:512–520

    CAS  PubMed  Google Scholar 

  9. Brunning RD, Matutes E, Flandrin G, Vardiman JW, Bennett J, Harris NL (2001) Acute myeloid leukaemia not otherwise categorised. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 91–105

  10. Das S, Prabhakar BR (1997) Acute myelofibrosis. Indian J Pathol Microbiol 40:527–530

    CAS  PubMed  Google Scholar 

  11. Del Potro E, Martinez R, Krsnik I, Lopez Rubio M, Gonzalez Fernandez A, Villegas A (1989) Myelofibrosis in primary myelodysplastic syndromes. Br J Haematol 73:281

    Google Scholar 

  12. Dzieciol J, Kemona A, Plonowski A, Sobaniec-Lotowska M, Sulkowski S, Musiatowicz B (1992) Acute myelosclerosis-morphological and clinical analysis of the case. A review of literature. Patol Pol 43:189–191

    CAS  PubMed  Google Scholar 

  13. Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489

    CAS  PubMed  Google Scholar 

  14. Fabich DR, Raich PC (1977) Acute myelofibrosis: a report of three cases. Am J Clin Pathol 67:334–338

    CAS  PubMed  Google Scholar 

  15. Fagioli F, Cuneo A, Piva N, Carli MG, Previati R, Balboni M, Tomasi P, Cariani D, Scapoli G, Castoldi G (1992) Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer 70:77–85

    CAS  PubMed  Google Scholar 

  16. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A et al (1993) PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 142:1359–1372

    CAS  PubMed  Google Scholar 

  17. Fohlmeister I, Fischer R, Modder B, Rister M, Schaefer HE (1985) Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 38:1218–1224

    CAS  PubMed  Google Scholar 

  18. Frisch B, Bartl R, Chaichik S (1986) Therapy-induced myelodysplasia and secondary leukaemia. Scand J Haematol Suppl 45:38–47

    CAS  PubMed  Google Scholar 

  19. Gallagher A, Darley RL, Padua R (1997) The molecular basis of myelodysplastic syndromes. Haematologica 82:191–204

    CAS  PubMed  Google Scholar 

  20. Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY (1988) The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology 13:257–267

    CAS  PubMed  Google Scholar 

  21. Hruban RH, Kuhajda FP, Mann RB (1987) Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am J Clin Pathol 88:578–588

    CAS  PubMed  Google Scholar 

  22. Imbert M, Nguyen D, Sultan C (1992) Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Leuk Res 16:51–54

    Article  CAS  PubMed  Google Scholar 

  23. Inoue Y, Matsubara A, Okuya S, Okafuji K, Kaku K, Kaneko T (1992) Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol 88:32–36

    CAS  PubMed  Google Scholar 

  24. Jacobs A, Geary C, Osman J (1993) Haematological disorders and occupational hazards: a British Society for Haematology/Health and Safety Executive Study. Br J Haematol 84:555–557

    CAS  PubMed  Google Scholar 

  25. Kamei S, Shinohara K, Oeda E (1993) Myelodysplastic syndrome associated with myelofibrosis, a report of 3 cases. Intern Med 32:668–671

    CAS  PubMed  Google Scholar 

  26. Karasick S, Karasick D, Schilling J (1982) Acute megakaryoblastic leukemia (acute “malignant” myelofibrosis): an unusual cause of osteosclerosis. Skeletal Radiol 9:45–46

    CAS  PubMed  Google Scholar 

  27. Knapp W, Rieber P, Dorken B, Schmidt RE, Stein H, vd Borne AE (1998) Towards a better definition of human leucocyte surface molecules. Immunol Today 10:253–258

    Article  Google Scholar 

  28. Krech R, Thiele J (1985) Histopathology of the bone marrow in toxic myelopathy. A study of drug induced lesions in 57 patients. Virchows Arch A Pathol Anat Histopathol 405:225–235

    CAS  PubMed  Google Scholar 

  29. Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D (1991) Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 78:161–166

    CAS  PubMed  Google Scholar 

  30. Lambertenghi-Deliliers G, Annaloro C, Oriani A, Soligo D (1992) Myelodysplastic syndrome associated with bone marrow fibrosis. Leuk Lymphoma 8:51–55

    CAS  PubMed  Google Scholar 

  31. Lewis SM, Szur L (1963) Malignant myelosclerosis. Br Med J 2:472–477

    Google Scholar 

  32. Lubin J, Rozen S, Rywlin M (1976) Malignant myelosclerosis. Arch Intern Med 136:141–145

    Article  CAS  PubMed  Google Scholar 

  33. Mangi MH, Mufti GJ (1992) Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 79:198–205

    CAS  PubMed  Google Scholar 

  34. Manoharan A, Pitney WR (1977) Acute myeloblastic leukaemia with marrow fibrosis (malignant myelosclerosis): acute leukaemia or malignant myelosclerosis? Aust N Z J Med 7:638–641

    CAS  PubMed  Google Scholar 

  35. Maschek H, Georgii A, Kaloutsi V, Werner M, Bandecar K, Kressel MG, Choritz H, Freund M, Hufnagl D (1992) Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 48:208–214

    CAS  PubMed  Google Scholar 

  36. Maschek H, Kaloutsi V, Rodriguez-Kaiser M, Werner M, Choritz H, Mainzer K, Dietzfelbinger M, Georgii A (1993) Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann Hematol 66:117–122

    CAS  PubMed  Google Scholar 

  37. Nakayama S (1988) Myelodysplastic syndrome and acute myelofibrosis. Nippon Ketsueki Gakkai Zasshi 51:1435–1440

    CAS  PubMed  Google Scholar 

  38. Narayanan MN, Benaim ME, Geary CG, Harrison CJ (1991) Hyperfibrotic myelodysplasia. Br J Haematol 79:653–655

    CAS  Google Scholar 

  39. den Ottolander GJ, te Velde J, Brederoo P, Geraedts JP, Slee PH, Willemze R, Zwaan FE, Haak HL, Muller HP, Bieger R (1979) Megakaryoblastic leukaemia (acute myelofibrosis): a report of three cases. Br J Haematol 42:9–20

    PubMed  Google Scholar 

  40. Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol 71:499–504

    CAS  PubMed  Google Scholar 

  41. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K (1990) Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083–1091

    CAS  PubMed  Google Scholar 

  42. Pinkus GS, Said JW (1977) Profile of intracytoplasmic lysozyme in normal tissues, myeloproliferative disorders, hairy cell leukemia, and other pathologic processes. An immunoperoxidase study of paraffin sections and smears. Am J Pathol 89:351–366

    CAS  PubMed  Google Scholar 

  43. Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK (2003) Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol 72:8–12

    Article  PubMed  Google Scholar 

  44. Reilly JT, Dolan G (1991) Proposed classification for the myelodysplasia/myelofibrosis syndromes. Br J Haematol 79:653

    CAS  Google Scholar 

  45. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A (1993) Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. Br J Haematol 83:58–62

    CAS  PubMed  Google Scholar 

  46. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G (1998) Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 103:189–197

    Article  CAS  PubMed  Google Scholar 

  47. Rojer RA, Mulder NH, Nieweg HO (1978) ‘Classic’ and ‘acute’ myelofibrosis. A retrospective study. Acta Haematol 60:108–116

    CAS  PubMed  Google Scholar 

  48. Rupani M (1982) Acute myelofibrosis. Am J Clin Pathol 77:475–478

    CAS  PubMed  Google Scholar 

  49. Saif MW, Hopkins JL, Gore SD (2002) Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 43:2083–2092

    Article  PubMed  Google Scholar 

  50. Singh M, Bofinger A, Taylor K, Ba Pe R (1994) Myelodysplasia with myelofibrosis-a distinct subgroup within the myelodysplastic syndromes. Pathology 26:69–71

    CAS  PubMed  Google Scholar 

  51. Soligo DA, Oriani A, Annaloro C, Cortelezzi A, Calori R, Pozzoli E, Nosella D, Orazi A, Deliliers GL (1994) CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. Am J Hematol 46:9–17

    CAS  PubMed  Google Scholar 

  52. Spector JI, Miller S (1978) Acute myelofibrosis with peripheral myeloblastosis: an acute myeloproliferative disorder. Arch Pathol Lab Med 102:564–566

    CAS  PubMed  Google Scholar 

  53. Steensma DP, Hanson CA, Letendre L, Tefferi A (2001) Myelodysplasia with fibrosis: a distinct entity? Leuk Res 25:829–838

    Article  CAS  PubMed  Google Scholar 

  54. Sultan C, Sigaux F, Imbert M, Reyes F (1981) Acute myelodysplasia with myelofibrosis: a report of eight cases. Br J Haematol 49:11–16

    CAS  PubMed  Google Scholar 

  55. Takahashi M, Koike T, Nagayama R, Fujiwara M, Koyama S, Ohnishi M, Nakamori Y, Soga N, Aoki S, Tatewaki W et al (1991) Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndrome as a major primary disorder for acute myelofibrosis. Clin Lab Haematol 13:17–23

    CAS  PubMed  Google Scholar 

  56. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H (1990) The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 75:1540–1548

    CAS  PubMed  Google Scholar 

  57. Thiele J, Krech R, Vykoupil KF, Georgii A (1984) Malignant (acute) myelosclerosis-a clinical and pathological study in 6 patients. Scand J Haematol 33:95–109

    CAS  PubMed  Google Scholar 

  58. Thiele J, Grashof K, Fisher R (1991) Follow-up study on bone marrow reticulin fibrosis in AML. Anal Cell Pathol 3:225–231

    CAS  PubMed  Google Scholar 

  59. Thiele J, Romatowski C, Wagner S, Dienemann D, Stein H, Fischer R, Falini B (1992) Macrophages (phagocytic–histiocytic reticular cells) in reactive-inflammatory lesions of the bone marrow and in myelodysplastic syndromes (MDS). An immunohistochemical and morphometric study by use of a new monoclonal antibody (PG-M1). Pathol Res Pract 188:995–1001

    CAS  PubMed  Google Scholar 

  60. Truong LD, Saleem A, Schwartz MR (1984) Acute myelofibrosis. A report of four cases and review of the literature. Medicine (Baltimore) 63:182–187

  61. Verhoef GE, De Wolf-Peeters C, Ferrant A, Deprez S, Meeus P, Stul M, Zachee P, Cassiman JJ, Van den Berghe H, Boogaerts MA (1991) Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 63:235–241

    CAS  PubMed  Google Scholar 

  62. West RR, Stafford DA, Farrow A, Jacobs A (1995) Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk Res 19:127–139

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are greatly indebted to Mrs. B. Rosenbach, Mrs. J. Maier, and Mr. G. Simons for their excellent technical assistance.

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Cologne, Joseph-Stelzmannstr. 9, 50924, Cologne, Germany

    J. Thiele, H. M. Kvasnicka & G. Zerhusen

  2. Department of Pathology, Medical Center, University of Chicago, Chicago, IL, USA

    J. Vardiman

  3. First Clinic of Medicine, University of Cologne, Cologne, Germany

    V. Diehl

  4. Department of Hematology, University of Freiburg, Freiburg, Germany

    M. Luebbert

  5. Institute of Pathology, University of Freiburg, Freiburg, Germany

    A. Schmitt-Graeff

Authors
  1. J. Thiele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Kvasnicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Zerhusen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Vardiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Luebbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Schmitt-Graeff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Thiele.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Kvasnicka, H.M., Zerhusen, G. et al. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol 83, 513–521 (2004). https://doi.org/10.1007/s00277-004-0881-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-004-0881-8

Keywords

Search

Navigation